NCT00482235已完成2 期
A Study of MK0359 in Patients With Chronic Obstructive Pulmonary Disease (COPD)(0359-016)
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 45
研究概览
简要总结
A study to test the effect of MK0359 in lessening the symptoms of COPD as compared to salmeterol and placebo.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 40 Years 至 75 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •You are between the ages of 40 and 75
- •You have had a history for at least a year of COPD symptoms
- •You have a history of smoking one pack of cigarettes per day for 10 years
排除标准
- •You have been in a research study with an investigational drug or vaccine in the last 4 weeks.
- •You have donated blood in the last 4 weeks.
- •You have been hospitalized or had major surgery in the last 4 weeks
- •You have been treated in the emergency room within the last 2 months or hospitalized within the last 3 months for your COPD symptoms
- •You have a history of heart problems in the last 6 months
- •You have a history of stomach problems
- •You are unwilling to avoid grapefruit juice throughout the study
研究者
相似试验
已完成
2 期
A Research Study of MK0633 in Patients With Chronic Obstructive Pulmonary Disease (COPD)(0633-009)(COMPLETED)Chronic Obstructive Pulmonary Disease (COPD)NCT00418613Merck Sharp & Dohme LLC266
已完成
2 期
Efficacy and Safety Study of MK0359 in Patients With Arthritis (0359-017)Rheumatoid ArthritisNCT00482417Merck Sharp & Dohme LLC11
已完成
3 期
Study in Patients With COPDCOPDNCT00215449Dey690
已完成
3 期
Clinical Evaluation Of GW815SF For Chronic Obstructive Pulmonary Disease (Chronic Bronchitis, Emphysema)Pulmonary Disease, Chronic ObstructiveNCT00269126GlaxoSmithKline150
已完成
不适用
Effect of Salmeterol on Fluid Clearance From Alveolar-Capillary Membrane in COPD PatientsSalmeterol Effect Against an Acute Alveolar Fluid Clearance Challenge Secondary to Lung Fluid Overload in COPD PatientsBronchodilator AgentsSalmeterolChronic Obstructive Pulmonary DiseaseNCT01271556University of Milan20
